Senator Ruben Gallego (D-AZ) has thrown his support behind the "Lower Drug Costs for Families Act," a legislative effort that aims to put a check on Big Pharma's pricing practices and promise relief to millions of Americans. According to a statement from his office, the bill, which also found advocates in the House, sets its sights on companies that hike prices beyond the rate of inflation, a long-standing issue that has seen families often caught between the necessities of health and sustenance.
"No Arizonan should have to choose between life-saving medication and putting food on the table," Gallego said, addressing an issue that has felt the heat of rising prescription costs. "For years, Big Pharma has been getting away with jacking up prices far beyond inflation, forcing families to cut pills, skip doses, or go without care altogether. We took a major step forward with the Inflation Reduction Act to lower drug costs for seniors, but it’s time to expand those protections to all Arizonans. This bill makes sure every Arizonan, no matter their insurance, is protected from prescription price gouging."
The Act not only garners strength from Gallego’s previous success with the Inflation Reduction Act, which brought down costs for Medicare beneficiaries, but also pledges to defend Americans subscribed to private insurances and those covered by employer-sponsored plans. With an eye on a long-term financial prize, the legislation seeks to extend the Medicare solvency by channeling the fines collected from overpricing directly into the Medicare Supplementary Medical Insurance Trust Fund. Originally introduced by Senators Catherine Cortez Masto (D-NV) and Amy Klobuchar (D-MN), this policy found allies among various labor unions and patient advocacy groups.
Anchoring the legislative push is a plan to hold drug companies accountable before calculating any penalties owed to Medicare for drug price hikes – in an attempt improperly ensure that Big Pharma is discouraged from exploiting over 180 million Americans with overpriced drugs. By expanding scrutiny beyond Medicare to include the commercial sector, the bill seems destined, should it pass, to act as a keystone in the archway of drug cost reformation. "This bill makes sure every Arizonan, no matter their insurance, is protected from prescription price gouging," Gallego reaffirmed the commitment echoed in his initial backing on his Senate page.
Senator Gallego's efforts align with a broader initiative he's consistent with, aiming to reduce the financial burden of healthcare on individuals. While serving in the House, he introduced legislation confronting out-of-step drug price increases and also supported a range of bills, such as the Promoting Access to Treatments and Increasing Extremely Needed Transparency (PATIENT) Act, designed to usher in an era of transparency within the notoriously opaque realm of drug pricing. With these endeavors, Gallego remains at the spearhead of the struggle against the high cost of staying alive.
